3-Deoxyglucosone and AGEs in uremic complications: Inactivation of glutathione peroxidase by 3-deoxyglucosone

This publication has 34 references indexed in Scilit:

• Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients.
  Journal of Clinical Investigation, 1997
• Determination of Advanced Glycation End Products in Serum by Fluorescence Spectroscopy and Competitive ELISA
  cclm, 1997
• Amyloid β2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis
  Kidney International, 1997
• Amyloid β2-microglobulin is modified with Nε-(carboxymethyl)lysine in dialysis-related amyloidosis
  Kidney International, 1996
• Induction of Apoptotic Cell Death by Methylglyoxal and 3-Deoxyglucosone in Macrophage-Derived Cell Lines
  Biochemical and Biophysical Research Communications, 1996
• Advanced oxidation protein products as a novel marker of oxidative stress in uremia
  Kidney International, 1996
• Elevated Serum Levels of 3-Deoxyglucosone, a Potent Protein-Cross-Linking Intermediate of the Maillard Reaction, in Uremic Patients
  Nephron, 1995
• Presence of 3-Deoxyglucosone, a Potent Protein Crosslinking Intermediate of Maillard Reaction, in Diabetic Serum
  Biochemical and Biophysical Research Communications, 1993
• beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.
  Journal of Clinical Investigation, 1993
• Metabolism of 3-deoxyglucosone, an intermediate compound in the Maillard reaction, administered orally or intravenously to rats
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1990